Ozempic May Reduce the Risk of Alzheimer’s. That’s Huge for Novo Nordisk.
Ozempic and Wegovy, the two brand names under which the company sells the GLP-1 drug semaglutide, are already blockbusters.
Novo Nordisk asks FDA to ban cheap copies of Wegovy, Ozempic, CNBC reports
Novo Nordisk (NVO) has asked the FDA to ban cheap copies of its weight loss drugs Wegovy and Ozempic, arguing they pose safety risks, ...
BioSpace41m
Novo’s Semaglutide Linked to Reduced Alzheimer’s Risk in Real-World Study
Researchers have linked Novo Nordisk’s semaglutide to a 40% to 70% reduction in the risk of Alzheimer’s disease diagnosis in ...
Diabetes patients worry about insulin shortages as Ozempic use skyrockets
Janel Wright had just days left in her insulin supply in early January when a pharmacist told her there was none of the drug ...
Benefits Pro14m
Top 5 states where people are 'normal weight'
When employees are of normal weight, that can help an employer save $31.55 per member per month on care for type 2 diabetes ...